Evicenter
Verzenio (abemaciclib) in HR-positive HER2-negative early breast cancer
Manufacturer
Lilly USA, LLC
Prescribing information
Verzenio (opens in a new tab)
Questions
27
Last updated

All questions

Safety: Verzenio (abemaciclib) in HR-positive HER2-negative early breast cancer

8 questions · 3 sources

Side effects

What are the most common side effects of Verzenio in early breast cancer?

Note: Columns are Verzenio plus tamoxifen or an aromatase inhibitor (N=2791: all grades, Grade 3, Grade 4) followed by tamoxifen or an aromatase inhibitor alone (N=2800: all grades, Grade 3, Grade 4), in percent, as in the table header.

What lab abnormalities occur with Verzenio in early breast cancer (monarchE)?

Note: Columns are Verzenio plus tamoxifen or an aromatase inhibitor (N=2791: all grades, Grade 3, Grade 4) followed by tamoxifen or an aromatase inhibitor alone (N=2800: all grades, Grade 3, Grade 4), in percent.

Does Verzenio cause hair loss in early breast cancer?

Note: Columns are Verzenio plus tamoxifen or an aromatase inhibitor (N=2791: all grades, Grade 3, Grade 4) followed by tamoxifen or an aromatase inhibitor alone (N=2800: all grades, Grade 3, Grade 4), in percent, as in the table header.

What serious side effects occurred with Verzenio in monarchE?

How often was Verzenio stopped or reduced for side effects (monarchE)?

How common is diarrhea with Verzenio in early breast cancer?

Note: These figures are presented on the managing diarrhea page of the Verzenio HCP site for patients with node-positive, high-risk, HR-positive, HER2-negative early breast cancer in monarchE.

Warnings

Can Verzenio cause lung problems (ILD or pneumonitis)?

Does Verzenio increase the risk of blood clots (VTE)?

Note: MONARCH 2, MONARCH 3, and EMBER-3 are trials in advanced or metastatic breast cancer (section 5.3 of the Prescribing Information); the monarchE rate is in the last passage.